| The Time in Therapeutic Range and Bleeding Complications of Warfarin in DifferentGeographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study. | Balkan Med J | 2017 Aug 4 | 28443575 |
| Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate WarfarinBioequivalence. | CPT Pharmacometrics Syst Pharmacol | 2017 Aug | 28379643 |
| Dietary implications for patients receiving long-term oral anticoagulationtherapy for treatment and prevention of thromboembolic disease. | Expert Rev Clin Pharmacol | 2017 Aug | 28635328 |
| 4-Hydroxy-7-methyl-3-phenylcoumarin Suppresses Aflatoxin Biosynthesis via Downregulation of aflK Expressing Versicolorin B Synthase in Aspergillus flavus. | Molecules | 2017 Apr 29 | 28468270 |
| Determination of rodenticides and related metabolites in rabbit liver andbiological matrices by liquid chromatography coupled to Orbitrap high resolution mass spectrometry. | J Pharm Biomed Anal | 2017 Apr 15 | 28160742 |
| Comparison of the Safety and Effectiveness of Apixaban versus Warfarin inPatients with Severe Renal Impairment. | Pharmacotherapy | 2017 Apr | 28117916 |
| Management of bleeding in patients receiving non-vitamin K antagonists. | Postgrad Med J | 2017 Apr | 27986971 |
| Interaction of quercetin and its metabolites with warfarin: Displacement ofwarfarin from serum albumin and inhibition of CYP2C9 enzyme. | Biomed Pharmacother | 2017 Apr | 28135601 |
| Is the clinical relevance of drug-food and drug-herb interactions limited tograpefruit juice and Saint-John's Wort? | Pharmacol Res | 2017 Apr | 27693910 |
| Laboratory Assessment of Direct Oral Anticoagulants. | Semin Thromb Hemost | 2017 Apr | 28249326 |